OMB INFORMATION COLLECTION SUPPORTING STATEMENT

First Page		Document Content
Date: 2005-10-06 10:05:35 Health Biologic License Application Center for Biologics Evaluation and Research Pharmaceutical industry Regulatory requirement Center for Drug Evaluation and Research Abbreviated New Drug Application Structured Product Labeling Prescription Drug User Fee Act Food and Drug Administration Pharmaceutical sciences Medicine		OMB INFORMATION COLLECTION SUPPORTING STATEMENT Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 105,50 KB Share Document on Facebook

	Investigator Responsibilities in Protecting Participants in the Conduct of Bioequivalence Studies Cecilia C. Maramba, MD, MScID DocID: 1ptht - View Document
	PUBLIC LAW 105–115—NOV. 21, 1997 FOOD AND DRUG ADMINISTRATION MODERIZATION ACT OF 1997 111 STAT. 2296 DocID: 1pnIy - View Document
	Updating ANDA Labeling After the Marketing Application for the Reference Listed Drug Has Been Withdrawn Guidance for Industry DocID: 1p93k - View Document
	Case 2:06-cvHAA-ES Document 71 FiledPage 1 of 45 PageID: 1673 NOT FOR PUBLICATION UNITED STATES DISTRICT COURT DocID: 1m2hg - View Document
	Microsoft Word - 10CV5118 Seattle Childrens Hosp v Akorn MTD.doc DocID: 1lmCl - View Document